CCL5 and neoplasm: As a refinement of this approach, we then used the RANTES/CCL5 promoter to help limit NIS transgene expression to the tumor environment and thus enhance tumor specificity, based on the fact that the RANTES gene is induced in MSC when they encounter the tumor milieu [32].